Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening
- PMID: 23034729
- PMCID: PMC3569614
- DOI: 10.1002/bjs.8897
Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening
Abstract
Background: The long-term effects of abdominal aortic aneurysm (AAA) screening were investigated in extended follow-up from the UK Multicentre Aneurysm Screening Study (MASS) randomized trial.
Methods: A population-based sample of men aged 65-74 years were randomized individually to invitation to ultrasound screening (invited group) or to a control group not offered screening. Patients with an AAA (3·0 cm or larger) detected at screening underwent surveillance and were offered surgery after predefined criteria had been met. Cause-specific mortality data were analysed using Cox regression.
Results: Some 67 770 men were enrolled in the study. Over 13 years, there were 224 AAA-related deaths in the invited group and 381 in the control group, a 42 (95 per cent confidence interval 31 to 51) per cent reduction. There was no evidence of effect on other causes of death, but there was an overall reduction in all-cause mortality of 3 (1 to 5) per cent. The degree of benefit seen in earlier years of follow-up was slightly diminished by the occurrence of AAA ruptures in those with an aorta originally screened normal. About half of these ruptures had a baseline aortic diameter in the range 2·5-2·9 cm. It was estimated that 216 men need to be invited to screening to save one death over the next 13 years.
Conclusion: Screening resulted in a reduction in all-cause mortality, and the benefit in AAA-related mortality continued to accumulate throughout follow-up.
Registration number: ISRCTN37381646 (http://www.controlled-trials.com).
Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
Figures



Comment in
-
Final follow-up of the Multicentre Aneurysm Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening (Br J Surg 2012; 99: 1649-1656).Br J Surg. 2012 Dec;99(12):1656. doi: 10.1002/bjs.8941. Br J Surg. 2012. PMID: 23132415 No abstract available.
-
ACP Journal Club. Screening for abdominal aortic aneurysm (AAA) in older men reduced AAA mortality at 13 years.Ann Intern Med. 2013 Jul 16;159(2):JC11. doi: 10.7326/0003-4819-159-2-201307160-02011. Ann Intern Med. 2013. PMID: 23856697 No abstract available.
References
-
- NHS Abdominal Aortic Aneurysm (AAA) Screening Programme: Annual Report 2010–11. http://www.aaa.screening.nhs.uk/annual_report [accessed 19 March 2012]
-
- Scottish Abdominal Aortic Aneurysm Screening Programme. http://www.scotland.gov.uk/Topics/Health/health/screening/AAAscreening [accessed 19 March 2012]
-
- Screening for Abdominal Aortic Aneurysm. 2008. http://www.sbu.se/en/Published/Alert/Screening-for-Abdominal-Aortic-Aneu... [accessed 19 March 2012]
-
- US Preventive Services Task Force. Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med. 2005;142:198–202. - PubMed
-
- Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA, et al. Multicentre Aneurysm Screening Study Group The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet. 2002;360:1531–1539. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous